Legacy Health System   Report issue

Academic/Hospital Phase 2 Phase 4
Founded: Portland OR United States (1989)

Organization Overview

First Clinical Trial
2004
NCT00246376
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2020

Timeline

NOW
  • Now

Alternative names

Legacy Community Health Center | Legacy Health | Legacy Health System | Legacy Research Institute, USA | Michael D. Straiko, MD | Nathalie Johnson | Physician within Legacy Health System

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Brain Neoplasms (Phase 2)

Breast Neoplasms (Phase 2)

Diabetes Mellitus, Type 1 (Phase 2)

Fibrosis (Phase 2)

Fuchs' Endothelial Dystrophy (Phase 2)

Glioma (Phase 2)

Idiopathic Pulmonary Fibrosis (Phase 2)

Pain, Postoperative (Phase 4)

Pulmonary Fibrosis (Phase 2)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 17
  • # of Trial APIs: 19